Funding
The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2022Objectively Measuring the Severity of Vocal and Speech-related Symptoms Associated with Parkinson’s Disease
Study Rationale: The ability to objectively measure vocal symptoms is necessary to better characterize the emergence and development of speech deficits, particularly in the early phases of Parkinson’s...
-
Therapeutic Pipeline Program, 2021Understand Me for Life: An Intelligibility App for Parkinson's Disease
Study Rationale:
Approximately 90% of people with Parkinson’s develop speech and language problems over the course of the disease, and more than half of these speakers experience problems with... -
Therapeutic Pipeline Program, 2014Augmenting Treatment Effects of Voice Therapy in Parkinson’s Disease
Study Rationale:
Speech and voice disorders are common in people with Parkinson’s disease (PD) and adversely affect their communication and quality of life. Presently, Lee Silverman... -
Computational Science, 2018Brain-inspired Computer Analysis of Complex Parkinson's Disease Data
Study Rationale:
Clinical research as well as wearable devices and phone apps used by people with Parkinson's disease (PD) generate large volumes of data, such as genetic and imaging data and data on... -
Research Grant, 2018The Role of FcgRIIb in Alpha-synuclein Toxicity and Spread
Study Rationale:
People with Parkinson's disease (PD) have clumps of protein alpha-synuclein in the brain. As PD progresses, these clumps spread through the brain, damaging nerve cells (neurons) that... -
Clinical Intervention Awards, 2007NH004 Films for Sialorrhea in PD Patients (2007)
Objective/Rationale:
The goal of the research is to advance the clinical development of NH004 for the control of sialorrhea (excessive drooling or uncontrolled salivation). NH004 is a dissolving film...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.